But David E. I. Pyott , Allergan 's chairman and chief executive , said in a conference call yesterday with analysts that he had talked Monday night to Nicholas L. Teti Jr. , president , chairman and chief executive of Inamed , and that Mr. Teti said he needed time to discuss the offer with his board and advisers .